Bio-Techne Corporation TECH

TECH Company Overview

Bio-Techne Corporation (NASDAQ: TECH) is a life sciences company that develops and manufactures specialized reagents, instruments, and diagnostic products used in biological research, clinical diagnostics, and cell and gene therapy workflows. The company operates primarily in the biotechnology and healthcare tools industries, serving pharmaceutical companies, academic and government research institutions, biotechnology firms, and clinical laboratories. Its core revenue drivers include protein analysis products, genomics and molecular diagnostics tools, cell culture reagents, and analytical instrumentation used across research and translational medicine applications.

The company traces its roots to Techne Corporation, founded in 1976, and expanded significantly through acquisitions and product diversification. A major milestone occurred in 2014 when Techne acquired R&D Systems, after which the combined organization adopted the Bio-Techne name. Over time, Bio-Techne built a portfolio spanning research reagents, diagnostic controls, exosome technologies, and spatial biology platforms. The company’s strategic positioning is supported by strong brand recognition in life sciences research, recurring consumables revenue, and an integrated portfolio serving both early-stage research and regulated clinical applications.